Showing results (131-140 of 210) with videos related to

Sort By:
Pageof 21
Journal of Clinical Medicine|January 21, 2023
From Bench to Bedside in Rheumatoid Arthritis from the "2022 GISEA International Symposium"Antonio Vitale, Stefano Alivernini, Roberto Caporali, et al.
Haematologica|December 18, 2023
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell diseaseAlessandro Mattè, Enrica Federti, Antonio Recchiuti, et al.
Clinical Rheumatology|April 21, 2021
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registryMarco Sebastiani, Vincenzo Venerito, Serena Bugatti, et al.
Journal of Clinical Medicine|October 27, 2022
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG SymposiumFulvia Ceccarelli, Marcello Govoni, Matteo Piga, et al.
Expert Opinion on Biological Therapy|October 19, 2020
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patientsDaniela Pugliese, Luisa Guidi, Giuseppe Privitera, et al.
Arthritis Care & Research|June 26, 2012
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicineElisa Gremese, Antonio Carletto, Melissa Padovan, et al.
Nature Communications|April 21, 2021
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritisYilin Wang, Aneesah Khan, Aristotelis Antonopoulos, et al.
Reumatismo|November 11, 2024
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel diseaseEnnio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, et al.
Joint Bone Spine|September 13, 2017
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugsFabiola Atzeni, Antonio Carletto, Rosario Foti, et al.
Annals of the Rheumatic Diseases|June 24, 2021
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study resultsJosef S Smolen, Stefan Siebert, Tatiana V Korotaeva, et al.
Pageof 21